Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2000 September; 1(3): 53–61.
Published online 2000 July 20. doi:  10.1208/pt010322
PMCID: PMC2750350

The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems


Amylose-ethylcellulose film coatings obtained from organic-based solvents were investigated as potential vehicles for colonic drug delivery. Amylose, in the form of an amylose-butan-1-ol dispersion, and ethylcellulose, dissolved in either ethyl lactate, ethanol, or propanol and plasticized with dibutyl sebacate, were mixed in various proportions and applied using a fluidized bed coater to achieve a range of film thicknesses on 5-aminosalicylic acid pellets. Drug release from the coated pellets was assessed under gastric and small intestinal conditions in the presence and absence of pepsin and pancreatin using dissolution methodology, and also within a simulated colonic environment involving fermentation testing with human feces in the form of a slurry. Under upper gastrointestinal tract conditions, the rate and extent of drug release were found to be related to the thickness of the coating and the ratio of amylose to ethylcellulose within the film. Modeling of the drug release data revealed that the ratio was more important than coat thickness in controlling drug release, irrespective of the solvent used for coating. Coatings with a thick film and/or low amylose content were relatively impermeable and able to delay drug release under conditions mimicking the upper gastrointestinal tract. Furthermore, drug release was unaffected by the presence of pepsin and pancreatin and by long-term storage. Under simulated colonic conditions, drug release was more pronounced from coating formulations containing higher proportions of amylose. Colon-specificity can therefore be achieved using such systems by judicious choice of the appropriate ratio of amylose to ethylcellulose and coat thickness.

Keywords: Amylose, Colonic Drug Delivery, Ethylcellulose, Film Coatings, Organic Solvents

Full Text

The Full Text of this article is available as a PDF (224K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Ashford M, Fell JT. Targeting drugs to the colon: Delivery systems for oral administration. J Drug Target. 1994;2:241–258. doi: 10.3109/10611869408996806. [PubMed] [Cross Ref]
2. Fish NW, Bloor JR. Drug delivery to the colon. Exp Opin Ther Patents. 1999;9:1515–1521. doi: 10.1517/13543776.9.11.1515. [Cross Ref]
3. Cummings JH, Milojevic S, Harding M, et al. In vivo studies of amylose- and ethylcellulose-coated [13C]glucose microspheres as a model for drug delivery to the colon. J Control Rel. 1996;40:123–131. doi: 10.1016/0168-3659(95)00186-7. [Cross Ref]
4. Englyst HN, Cummings JH. Resistant starch, a ‘new’ food component: A classification of starch for nutritional purposes. In: Morton ID, editor. Cereals in a European context. First European Conference on Food Science and Technology. Chichester, England: Ellis Horwood; 1987. pp. 221–233.
5. Ring SG, Gee JM, Whittam M, Orford P., Johnson IT. Resistant starch: its chemical form in foodstuffs and effect on digestibility in vitro. Food Chem. 1988;28:97–109. doi: 10.1016/0308-8146(88)90139-2. [Cross Ref]
6. Allwood MC, Archer DB, Ring SG. Delayed release formulations. US patent 5108758. 1989.
7. Macfarlane GT, Englyst HN. Starch utilization by the human large intestinal microflora. J Appl Bacteriol. 1986;60:195–201. [PubMed]
8. Ring SG, Archer DB, Allwood MC, Newton JM. Delayed release formulations. US patent 5294448. 1992.
9. Milojevic S, Newton JM, Cummings JH, et al. Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using-aminosalicylic acid pellets. J Control Rel. 1996;38:75–84. doi: 10.1016/0168-3659(95)00112-3. [Cross Ref]
10. Milojevic S, Newton JM, Cummings JH, et al. Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets. J Control Rel. 1996;38:85–94. doi: 10.1016/0168-3659(95)00113-1. [Cross Ref]
11. Basit AW. Oral colon-specific drug delivery using amylose-based film coatings. Pharm Technol Eur. 2000;12:30–36.
12. Siew LF, Basit AW, Newton JM. The properties of amylose-ethylcellulose films cast from organic-based solvents as potential coatings for colonic drug delivery. Eur J Pharm Sci. 2000;11:133–139. doi: 10.1016/S0928-0987(00)00098-1. [PubMed] [Cross Ref]
13. Ellis HS, Ring SG. A study of some factors influencing amylose gelation. Carbohdr Polym. 1985;5:201–213. doi: 10.1016/0144-8617(85)90022-0. [Cross Ref]
14. Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine. Gut. 1986;27:886–892. doi: 10.1136/gut.27.8.886. [PMC free article] [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists